Our analyses showed that the level of the PD-1 receptor expression in the blood samples, depending on the stage of the disease (G), was statistically significant for the CD8+ T cells, while in the tumor and lymph node samples, significant expression of this molecule was found on the CD4+ and CD8+ T cells. The gene discussed is CD4; the disease is neoplasm.